Claire H. Li

发表

Incidence and management of CAR-T neurotoxicity in patients with multiple myeloma treated with ciltacabtagene autoleucel in CARTITUDE studies

H. Einsele, S. Jagannath, A. Jakubowiak, 2022, Blood Cancer Journal.

Modeling and simulation applications with potential impact in drug development and patient care

Claire H. Li, 2014 .

Experimental Medicine Study to Measure Immune Checkpoint Receptors PD‐1 and GITR Turnover Rates In Vivo in Humans

Michael E. Lassman, O. Laterza, D. Alwis, 2020, Clinical pharmacology and therapeutics.

Pharmacogenomics of Gemcitabine Metabolism: Functional Analysis of Genetic Variants in Cytidine Deaminase and Deoxycytidine Kinase

B. Ring, S. Wrighton, Y. Qian, 2013, Drug Metabolism and Disposition.

Prediction of brain clozapine and norclozapine concentrations in humans from a scaled pharmacokinetic model for rat brain and plasma pharmacokinetics

B. Pollock, G. Remington, B. Mulsant, 2014, Journal of Translational Medicine.

Evaluation of dosing strategy for pembrolizumab for oncology indications

D. D. de Alwis, J. Stone, T. Freshwater, 2017, Journal of Immunotherapy for Cancer.

CYP3A5 genotype and its impact on vincristine pharmacokinetics and development of neuropathy in Kenyan children with cancer

G. Kaspers, T. Vik, E. Smith, 2018, Pediatric blood & cancer.

Clinical trial simulation to evaluate population pharmacokinetics and food effect: Capturing abiraterone and nilotinib exposures

R. Bies, L. Lewis, E. Sherer, 2015, Journal of clinical pharmacology.

Time dependent pharmacokinetics of pembrolizumab in patients with solid tumor and its correlation with best overall response

Jiang Liu, P. Keegan, M. Chatterjee, 2017, Journal of Pharmacokinetics and Pharmacodynamics.

Current treatment landscape for patients with locally recurrent inoperable or metastatic triple-negative breast cancer: a systematic literature review

V. Karantza, Mallika Lala, G. Aktan, 2019, Breast Cancer Research.

Population Pharmacokinetic Modeling of Ziprasidone in Patients With Schizophrenia From the CATIE Study

J. Lieberman, S. Stroup, L. Schneider, 2011, Journal of clinical pharmacology.

Genetic Variants Associated With Vincristine‐Induced Peripheral Neuropathy in Two Populations of Children With Acute Lymphoblastic Leukemia

Elizabeth M. Wells, N. Winick, E. Smith, 2019, Clinical pharmacology and therapeutics.

Time dependent pharmacokinetics of pembrolizumab in patients with solid tumor and its correlation with best overall response

Manash S. Chatterjee, Jiang Liu, P. Keegan, 2017, Journal of Pharmacokinetics and Pharmacodynamics.

Population Pharmacokinetic Modeling of Sertraline Treatment in Patients With Alzheimer Disease: The DIADS‐2 Study

C. Lyketsos, B. Pollock, R. Bies, 2013, Journal of clinical pharmacology.

Model‐Based Characterization of the Pharmacokinetics of Pembrolizumab: A Humanized Anti–PD‐1 Monoclonal Antibody in Advanced Solid Tumors

J. Stone, J. Elassaiss-Schaap, T. Freshwater, 2016, CPT: pharmacometrics & systems pharmacology.